Exact Mass: 606.4244

Exact Mass Matches: 606.4244

Found 87 metabolites which its exact mass value is equals to given mass value 606.4244, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PA(10:0/19:0)

[(2R)-3-(decanoyloxy)-2-(nonadecanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(10:0/19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/19:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of nonadecylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(15:0/14:0)

[(2R)-3-(pentadecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(15:0/14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(15:0/14:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(21:0/8:0)

[(2R)-3-(henicosanoyloxy)-2-(octanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(21:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(21:0/8:0), in particular, consists of one chain of heneicosylic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/21:0)

[(2R)-2-(henicosanoyloxy)-3-(octanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(8:0/21:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/21:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of heneicosylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(10:0/i-19:0)

[(2R)-3-(decanoyloxy)-2-[(17-methyloctadecanoyl)oxy]propoxy]phosphonic acid

C32H63O8P (606.426)


PA(10:0/i-19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-19:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/a-21:0)

[(2R)-2-[(18-methylicosanoyl)oxy]-3-(octanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(8:0/a-21:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/a-21:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of anteisoheneicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/i-21:0)

[(2R)-2-[(19-methylicosanoyl)oxy]-3-(octanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(8:0/i-21:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-21:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isoheneicosanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(a-13:0/i-16:0)

[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(14-methylpentadecanoyl)oxy]propoxy]phosphonic acid

C32H63O8P (606.426)


PA(a-13:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-16:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(a-21:0/8:0)

[(2R)-3-[(18-methylicosanoyl)oxy]-2-(octanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(a-21:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-21:0/8:0), in particular, consists of one chain of anteisoheneicosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-12:0/a-17:0)

[(2R)-2-[(14-methylhexadecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C32H63O8P (606.426)


PA(i-12:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/a-17:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-12:0/i-17:0)

[(2R)-2-[(15-methylhexadecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C32H63O8P (606.426)


PA(i-12:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-17:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-13:0/i-16:0)

[(2R)-3-[(11-methyldodecanoyl)oxy]-2-[(14-methylpentadecanoyl)oxy]propoxy]phosphonic acid

C32H63O8P (606.426)


PA(i-13:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-16:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-14:0/a-15:0)

[(2R)-2-[(12-methyltetradecanoyl)oxy]-3-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C32H63O8P (606.426)


PA(i-14:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/a-15:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-14:0/i-15:0)

[(2R)-2-[(13-methyltetradecanoyl)oxy]-3-[(12-methyltridecanoyl)oxy]propoxy]phosphonic acid

C32H63O8P (606.426)


PA(i-14:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-15:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-21:0/8:0)

[(2R)-3-[(19-methylicosanoyl)oxy]-2-(octanoyloxy)propoxy]phosphonic acid

C32H63O8P (606.426)


PA(i-21:0/8:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-21:0/8:0), in particular, consists of one chain of isoheneicosanoic acid at the C-1 position and one chain of caprylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   
   

Dammarenediol II 3-O-caffeate

Dammarenediol II 3-O-caffeate

C39H58O5 (606.4284)


   

21alpha-hydroxyserrat-14-en-3beta-yl p-dihydrocaffeate|Phlegmanol A

21alpha-hydroxyserrat-14-en-3beta-yl p-dihydrocaffeate|Phlegmanol A

C39H58O5 (606.4284)


   

PA(12:0/17:0)

1-dodecanoyl-2-heptadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

PA(13:0/16:0)

1-tridecanoyl-2-hexadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

PA(15:0/14:0)

1-pentadecanoyl-2-tetradecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

PA(16:0/13:0)

1-hexadecanoyl-2-tridecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

PA(17:0/12:0)

1-heptadecanoyl-2-dodecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

PA(14:0/15:0)

1-tetradecanoyl-2-pentadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

PA 29:0

1-tetradecanoyl-2-pentadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   
   

WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCCCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1

WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCCCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1

C32H62O10 (606.4343)


   

NAGlySer 11:0/18:3

NAGlySer 11:0/18:3

C34H58N2O7 (606.4244)


   

NAGlySer 16:2/13:1

NAGlySer 16:2/13:1

C34H58N2O7 (606.4244)


   

NAGlySer 13:1/16:2

NAGlySer 13:1/16:2

C34H58N2O7 (606.4244)


   

NAGlySer 18:3/11:0

NAGlySer 18:3/11:0

C34H58N2O7 (606.4244)


   

NAGlySer 13:0/16:3

NAGlySer 13:0/16:3

C34H58N2O7 (606.4244)


   

NAGlySer 16:3/13:0

NAGlySer 16:3/13:0

C34H58N2O7 (606.4244)


   

2,3-dihydroxypropyl [3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-hydroxypropyl] hydrogen phosphate

2,3-dihydroxypropyl [3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-hydroxypropyl] hydrogen phosphate

C32H63O8P (606.426)


   

PEtOH 12:0_15:0

PEtOH 12:0_15:0

C32H63O8P (606.426)


   

PMeOH 12:0_16:0

PMeOH 12:0_16:0

C32H63O8P (606.426)


   

PMeOH 13:0_15:0

PMeOH 13:0_15:0

C32H63O8P (606.426)


   

PEtOH 13:0_14:0

PEtOH 13:0_14:0

C32H63O8P (606.426)


   

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptacosanoate

(1-Acetyloxy-3-phosphonooxypropan-2-yl) heptacosanoate

C32H63O8P (606.426)


   

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate

C32H63O8P (606.426)


   

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) pentacosanoate

C32H63O8P (606.426)


   

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C32H63O8P (606.426)


   

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C32H63O8P (606.426)


   

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C32H63O8P (606.426)


   

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexacosanoate

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) hexacosanoate

C32H63O8P (606.426)


   

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

C32H63O8P (606.426)


   

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C32H63O8P (606.426)


   

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) hexadecanoate

(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) hexadecanoate

C32H63O8P (606.426)


   

(1-Phosphonooxy-3-tetradecanoyloxypropan-2-yl) pentadecanoate

(1-Phosphonooxy-3-tetradecanoyloxypropan-2-yl) pentadecanoate

C32H63O8P (606.426)


   

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) octadecanoate

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) octadecanoate

C32H63O8P (606.426)


   

[3-hydroxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[3-hydroxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C39H58O5 (606.4284)


   

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

C32H63O8P (606.426)


   

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] octadecanoate

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] octadecanoate

C32H63O8P (606.426)


   

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] octadecanoate

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] octadecanoate

C32H63O8P (606.426)


   

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C39H58O5 (606.4284)


   

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate

C39H58O5 (606.4284)


   

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C39H58O5 (606.4284)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] nonadecanoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] nonadecanoate

C32H63O8P (606.426)


   

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

C39H58O5 (606.4284)


   

1-pentadecanoyl-2-tetradecanoyl-glycero-3-phosphate

1-pentadecanoyl-2-tetradecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

1-dodecanoyl-2-heptadecanoyl-glycero-3-phosphate

1-dodecanoyl-2-heptadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

1-hexadecanoyl-2-tridecanoyl-glycero-3-phosphate

1-hexadecanoyl-2-tridecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

1-heptadecanoyl-2-lauroyl-sn-glycero-3-phosphate

1-heptadecanoyl-2-lauroyl-sn-glycero-3-phosphate

C32H63O8P (606.426)


A 1,2-diacyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and lauroyl respectively.

   

1-tetradecanoyl-2-pentadecanoyl-glycero-3-phosphate

1-tetradecanoyl-2-pentadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

1-tridecanoyl-2-hexadecanoyl-glycero-3-phosphate

1-tridecanoyl-2-hexadecanoyl-glycero-3-phosphate

C32H63O8P (606.426)


   

MGDG O-23:0;O

MGDG O-23:0;O

C32H62O10 (606.4343)


   

PA O-20:0/9:1;O

PA O-20:0/9:1;O

C32H63O8P (606.426)


   

PA O-29:1;O

PA O-29:1;O

C32H63O8P (606.426)


   

PA 10:0_19:0

PA 10:0_19:0

C32H63O8P (606.426)


   

PA 11:0_18:0

PA 11:0_18:0

C32H63O8P (606.426)


   

PA 12:0_17:0

PA 12:0_17:0

C32H63O8P (606.426)


   

PA 13:0_16:0

PA 13:0_16:0

C32H63O8P (606.426)


   

PA 14:0_15:0

PA 14:0_15:0

C32H63O8P (606.426)


   

PA 25:0/4:0

PA 25:0/4:0

C32H63O8P (606.426)


   

PA 27:0/2:0

PA 27:0/2:0

C32H63O8P (606.426)


   
   
   

(1r,3ar,3br,5as,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

(1r,3ar,3br,5as,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)


   

19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(3,4-dihydroxyphenyl)propanoate

19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(3,4-dihydroxyphenyl)propanoate

C39H58O5 (606.4284)


   

(1s,3ar,3br,5as,7s,9ar,9br,11ar)-1-[(2s,5e)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1s,3ar,3br,5as,7s,9ar,9br,11ar)-1-[(2s,5e)-2,7-dihydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)


   

(1r,3s,4r,5s)-3,4,5-trihydroxy-1-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexyl henicosanoate

(1r,3s,4r,5s)-3,4,5-trihydroxy-1-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexyl henicosanoate

C34H58N2O7 (606.4244)


   

(1s,3r,4s,5s)-3,4,5-trihydroxy-1-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexyl henicosanoate

(1s,3r,4s,5s)-3,4,5-trihydroxy-1-[2-(1,3-oxazol-5-ylmethyl)-1,3-oxazol-4-yl]hexyl henicosanoate

C34H58N2O7 (606.4244)


   

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)


   

(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(3,4-dihydroxyphenyl)propanoate

(3s,6r,8s,11r,12s,15s,16r,19s,21r)-19-hydroxy-3,7,7,11,16,20,20-heptamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-1(23)-en-8-yl 3-(3,4-dihydroxyphenyl)propanoate

C39H58O5 (606.4284)


   

1-(2,7-dihydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxyphenyl)prop-2-enoate

1-(2,7-dihydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)


   

1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

1-(2-hydroxy-6-methylhept-5-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H58O5 (606.4284)